Literature DB >> 2161750

Biphasic effects of transforming growth factor-beta on the production of osteoclast-like cells in mouse bone marrow cultures: the role of prostaglandins in the generation of these cells.

D M Shinar1, G A Rodan.   

Abstract

Osteoclast-like multinucleated giant cells are induced in bone marrow cultures by 1,25-dihydroxyvitamin D3 and other agents. These cells resemble osteoclasts in their morphology, their ability to resorb bone, and the possession of calcitonin receptors. We report here a biphasic effect of transforming growth factor-beta (TGF beta) on the generation of these cells in mouse bone marrow cultures. At low concentrations (10-100 pg/ml) TGF beta enhanced 1,25-dihydroxyvitamin D3-dependent production of osteoclast-like cells, while at higher concentrations TGF beta was inhibitory. Complete inhibition was seen at 4 ng/ml. Antibodies directed against TGF beta significantly reduced the generation of osteoclast-like cells in 1,25-dihydroxyvitamin D3-treated cultures, indicating the contribution of endogenous TGF beta activity. TGF beta also enhanced the accumulation of prostaglandin E2 (PGE2) in a dose-dependent manner. Moreover, we found that the generation of these cells in response to 1,25-dihydroxyvitamin D3 was also dependent on PG accumulation, since it was inhibited by indomethacin (250 ng/ml), and this inhibition could be reversed by exogenous PGE2. It is, thus, suggested that PG activity, probably PGE2, mediates the enhancing effect of low TGF beta concentrations and is required for the generation of osteoclast-like cells in this system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161750     DOI: 10.1210/endo-126-6-3153

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  22 in total

1.  Inhibition of prostaglandin synthesis leads to a change in adherence of mouse osteoclasts from bone to periosteum.

Authors:  M J Marshall; I Holt; M W Davie
Journal:  Calcif Tissue Int       Date:  1996-09       Impact factor: 4.333

2.  Characterization of zinc effect to inhibit osteoclast-like cell formation in mouse marrow culture: interaction with dexamethasone.

Authors:  S Kishi; M Yamaguchi
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

3.  Transforming growth factor beta 1-induced cellular heterogeneity in the periosteum of rat parietal bones.

Authors:  Y Taniguchi; T Tanaka; K Gotoh; R Satoh; M Inazu
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

4.  Interleukin-11: a new cytokine critical for osteoclast development.

Authors:  G Girasole; G Passeri; R L Jilka; S C Manolagas
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

5.  Giant cell tumor of bone: a neoplasm or a reactive condition?

Authors:  Anwar Ul Haque; Ambreen Moatasim
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 6.  Prostaglandins: mechanisms of action and regulation of production in bone.

Authors:  L G Raisz; C C Pilbeam; P M Fall
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

7.  Roles of stromal cell RANKL, OPG, and M-CSF expression in biphasic TGF-beta regulation of osteoclast differentiation.

Authors:  Mary Karst; Genevieve Gorny; Rachelle J Sells Galvin; Merry Jo Oursler
Journal:  J Cell Physiol       Date:  2004-07       Impact factor: 6.384

8.  Treatment with α-lipoic acid enhances the bone healing after femoral fracture model of rats.

Authors:  Ali Aydin; Zekai Halici; Ayhan Akoz; Adem Karaman; Irmak Ferah; Yasin Bayir; A Murat Aksakal; Erol Akpinar; Jale Selli; Halim Kovaci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-07-20       Impact factor: 3.000

9.  Low transforming growth factor-beta1 serum levels in idiopathic male osteoporosis.

Authors:  B Akinci; F Bayraktar; A Saklamaz; T Demir; S Yener; A Comlekci; M A Ozcan; L Kebapcilar; F Yuksel; S Yesil
Journal:  J Endocrinol Invest       Date:  2007-05       Impact factor: 4.256

10.  An assessment of the ability of human bone marrow cultures to generate osteoclasts.

Authors:  A M Flanagan; M A Horton; E L Dorey; D A Collins; R S Evely; J M Moseley; F C Firkin; T J Chambers; M H Helfrich; T J Martin
Journal:  Int J Exp Pathol       Date:  1992-06       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.